X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (26) 26
index medicus (26) 26
melanoma (18) 18
oncology (13) 13
article (10) 10
cell biology (10) 10
cancer (9) 9
female (9) 9
metastatic melanoma (9) 9
mutation (9) 9
immunotherapy (8) 8
male (7) 7
melanoma - genetics (7) 7
surgery (7) 7
analysis (6) 6
biochemistry & molecular biology (6) 6
cell line, tumor (6) 6
prognosis (6) 6
tumors (6) 6
adult (5) 5
aged (5) 5
animals (5) 5
medicine & public health (5) 5
melanoma - drug therapy (5) 5
melanoma - pathology (5) 5
metastasis (5) 5
mice (5) 5
middle aged (5) 5
proto-oncogene proteins b-raf - genetics (5) 5
apoptosis (4) 4
cancer-immunotherapy (4) 4
dermatology (4) 4
metastases (4) 4
neoplasms - genetics (4) 4
pd-1 blockade (4) 4
protein kinase inhibitors - pharmacology (4) 4
sentinel lymph node biopsy (4) 4
skin neoplasms - genetics (4) 4
surgical oncology (4) 4
abridged index medicus (3) 3
acquired-resistance (3) 3
aged, 80 and over (3) 3
antineoplastic agents - pharmacology (3) 3
biomarkers (3) 3
braf (3) 3
cancer therapies (3) 3
care and treatment (3) 3
drug resistance, neoplasm (3) 3
gene expression (3) 3
gene mutations (3) 3
genomics (3) 3
health aspects (3) 3
immunohistochemistry (3) 3
medical colleges (3) 3
mek inhibition (3) 3
mutations (3) 3
neoplasm staging (3) 3
nras (3) 3
pathway (3) 3
patients (3) 3
pd-1 (3) 3
pd-1 protein (3) 3
proteins (3) 3
proto-oncogene proteins b-raf - antagonists & inhibitors (3) 3
rna (3) 3
signal transduction (3) 3
signal transduction - drug effects (3) 3
skin neoplasms - pathology (3) 3
survival (3) 3
t cells (3) 3
therapy (3) 3
actionable genes (2) 2
antigens (2) 2
antineoplastic agents, immunological - pharmacology (2) 2
antitumor-activity (2) 2
bioindicators (2) 2
biopsy (2) 2
braf mutations (2) 2
breast (2) 2
carcinoma, merkel cell - mortality (2) 2
cd8 (2) 2
cd8 antigen (2) 2
cd8+ t cells (2) 2
cell cycle (2) 2
cell death (2) 2
cell differentiation (2) 2
cell proliferation (2) 2
colon cancer (2) 2
combined modality therapy (2) 2
ctla-4 blockade (2) 2
cutaneous melanoma (2) 2
cytokines (2) 2
development and progression (2) 2
drug development (2) 2
drug resistance (2) 2
drug resistance, neoplasm - drug effects (2) 2
drug resistance, neoplasm - genetics (2) 2
enzyme activation - drug effects (2) 2
flow cytometry (2) 2
follow-up studies (2) 2
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of Surgical Oncology, ISSN 0022-4790, 01/2015, Volume 111, Issue 1, pp. 3 - 8
Journal Article
by Akbani, Rehan and Akdemir, Kadir C and Aksoy, B. Arman and Albert, Monique and Ally, Adrian and Amin, Samirkumar B and Arachchi, Harindra and Arora, Arshi and Auman, J. Todd and Ayala, Brenda and Baboud, Julien and Balasundaram, Miruna and Balu, Saianand and Barnabas, Nandita and Bartlett, John and Bartlett, Pam and Bastian, Boris C and Baylin, Stephen B and Behera, Madhusmita and Belyaev, Dmitry and Benz, Christopher and Bernard, Brady and Beroukhim, Rameen and Bir, Natalie and Black, Aaron D and Bodenheimer, Tom and Boice, Lori and Boland, Genevieve M and Bono, Riccardo and Bootwalla, Moiz S and Bosenberg, Marcus and Bowen, Jay and Bowlby, Reanne and Bristow, Christopher A and Brockway-Lunardi, Laura and Brooks, Denise and Brzezinski, Jakub and Bshara, Wiam and Buda, Elizabeth and Burns, William R and Butterfield, Yaron S.N and Button, Michael and Calderone, Tiffany and Cappellini, Giancarlo Antonini and Carter, Candace and Carter, Scott L and Cherney, Lynn and Cherniack, Andrew D and Chevalier, Aaron and Chin, Lynda and Cho, Juok and Cho, Raymond J and Choi, Yoon-La and Chu, Andy and Chudamani, Sudha and Cibulskis, Kristian and Ciriello, Giovanni and Clarke, Amanda and Coons, Stephen and Cope, Leslie and Crain, Daniel and Curley, Erin and Danilova, Ludmila and D’Atri, Stefania and Davidsen, Tanja and Davies, Michael A and Delman, Keith A and Demchok, John A and Deng, Qixia A and Deribe, Yonathan Lissanu and Dhalla, Noreen and Dhir, Rajiv and DiCara, Daniel and Dinikin, Michael and Dubina, Michael and Ebrom, J. Stephen and Egea, Sophie and Eley, Greg and Engel, Jay and Eschbacher, Jennifer M and Fedosenko, Konstantin V and Felau, Ina and Fennell, Timothy and Ferguson, Martin L and Fisher, Sheila and Flaherty, Keith T and Frazer, Scott and Frick, Jessica and Fulidou, Victoria and Gabriel, Stacey B and Gao, Jianjiong and Gardner, Johanna and Garraway, Levi A and Gastier-Foster, Julie M and Gaudioso, Carmelo and Gehlenborg, Nils and Genovese, Giannicola and Gerken, Mark and Gershenwald, Jeffrey E and Getz, Gad and ... and Canc Genome Atlas Network and Cancer Genome Atlas Network
Cell, ISSN 0092-8674, 06/2015, Volume 161, Issue 7, pp. 1681 - 1696
Journal Article
Nature Communications, ISSN 2041-1723, 12/2017, Volume 8, Issue 1, pp. 1136 - 11
Journal Article
Journal of Investigative Dermatology, ISSN 0022-202X, 12/2017, Volume 137, Issue 12, pp. 2466 - 2468
Melanoma demonstrates considerable biological heterogeneity and is associated with several routes of dissemination including lymphatic and hematogenous.... 
TRIAL | MULTICENTER | SENTINEL-NODE BIOPSY | DISSECTION | DERMATOLOGY | Registries | Lymphatic Metastasis | Prognosis | Humans | Melanoma | Skin Neoplasms | Index Medicus
Journal Article
Journal Article
Journal Article
Clinical Cancer Research, ISSN 1078-0432, 08/2019, p. clincanres.0253.2019
PURPOSETreatment of BRAFV600E -mutant melanomas with mitogen-activated protein kinase inhibitors (MAPKi) results in significant tumor regression, but acquired... 
Index Medicus
Journal Article
Journal of Clinical Investigation, ISSN 0021-9738, 04/2015, Volume 125, Issue 4, pp. 1459 - 1470
Multiple mechanisms have been described that confer BRAF inhibitor resistance to melanomas, yet the basis of this resistance remains undefined in a sizable... 
DABRAFENIB | MEDICINE, RESEARCH & EXPERIMENTAL | RAF INHIBITION | NRAS | MEK INHIBITION | MUTATION | ACQUIRED-RESISTANCE | PATIENT | REVEALS | BRAF(V600E) | VEMURAFENIB | Humans | Melanoma, Experimental - drug therapy | PTEN Phosphohydrolase - physiology | Oximes - therapeutic use | Drug Resistance, Neoplasm | Melanoma, Experimental - metabolism | Neoplasm Proteins - antagonists & inhibitors | Antineoplastic Agents - therapeutic use | Gene Expression Profiling | Melanoma - genetics | Antineoplastic Agents - pharmacology | Imidazoles - therapeutic use | Neoplasm Proteins - genetics | Transgenes | Melanoma - metabolism | Neoplasm Proteins - biosynthesis | Imidazoles - pharmacology | Proto-Oncogene Proteins B-raf - antagonists & inhibitors | Animals | Melanoma, Experimental - genetics | Protein Kinase Inhibitors - therapeutic use | Proto-Oncogene Proteins B-raf - genetics | Melanoma - drug therapy | Tamoxifen - pharmacology | Oximes - pharmacology | Doxycycline - pharmacology | Mice | Protein Kinase Inhibitors - pharmacology | Development and progression | Genetic aspects | Gene mutations | Drug resistance | Health aspects | Melanoma | Proteins | Endangered & extinct species | Medical research | Extinction | Rodents | Cell cycle | Mutation | Gene expression | CFR | Tumors | Cancer | Index Medicus | Abridged Index Medicus
Journal Article
Journal Article